“Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor”. Journal of Regulatory Science, vol. 7, Feb. 2019, pp. 1-9, https://doi.org/10.21423/JRS-V07SHIBATA.